Heart Disease Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who are over 18 years of age
- People who understand what the trial involves and agree to take part by signing a consent form
- People for whom a doctor has recommended a heart procedure (called PCI) that involves placing a stent, and who would receive at least one specific device called the DynamX Bioadaptor as part of that procedure
Who may not be able to join:
- People whose blocked artery is located in a specific area of the heart called the left main artery
- People who have previously had a bypass graft surgery using a vein or artery
- People who have a blockage that has developed inside a previously placed stent (known as in-stent restenosis)
- People who are currently taking part in another clinical trial testing an unapproved device or drug — particularly one involving blood-thinning or anti-clotting medications — where that trial has not yet reached its main measurement point
- People whom the trial doctor considers unable to follow the study requirements, or who are considered unsuitable for the registry for any reason
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: +1 408 636 2000
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Device Oriented Clinical Endpoint
Can't join this trial?
Data last synced from ClinicalTrials.gov: 20 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.